We fund high impact chordoma research that addresses research priorities defined by our medical and scientific advisors. Current funding priorities include but are not limited to target discovery, predictive biomarkers, mechanisms of immune evasion, and brachyury (also known as TBXT) drug discovery. Funding opportunities will be listed below when open, and you can sign up to be notified of future funding opportunities. Additionally, funding requests will be considered at any time and can be initiated by submitting a one-page letter of intent, including specific aims and estimated budget, to our research team.
We're thrilled to announce the launch of our TBXT Challenge — a new prize competition aimed at conquering one of the most formidable challenges in chordoma treatment: developing drugs that can effectively target TBXT, also known as brachyury.